Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Onset of Action of Loratadine and Fexofenadine in Seasonal Allergic Rhinitis
NCT01469234Phase 4Completed
- Sponsor
- Bayer
- Start
- Oct 2011
- Primary completion
- Nov 2011
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of loratadine in seasonal allergic rhinitis (SAR), sponsored by Bayer. Started Oct 2011; status: completed.
02
Drugs
loratadine
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT01469234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01469234.